Lung Cancer Therapeutics Market Size And Share

  • Report Code : TIPRE00004083
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Principales conclusions et analyse des parts de marché des thérapies contre le cancer du poumon d'ici 2025-2031

Buy Now

Lung Cancer Therapeutics Market Report Lung Cancer Therapeutics Market Scope and Analysis Lung Cancer Therapeutics Market Size and Share

Lung Cancer Therapeutics Market Report Analysis

Lung Cancer Therapeutics Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Astellas Pharma
  • Pfizer
  • Amgen
  • Celgene
  • AstraZeneca
  • F. HofmannLa Roche
  • GlaxoSmithKline
  • Aetna, Agennix
  • Eli Lilly

Regional Overview

  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique

Market Segmentation

By Type de maladie
  • cancer du poumon non à petites cellules
  • cancer du poumon à petites cellules
By Type de molécule
  • petites molécules
  • produits biologiques
By Géographie
  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et Centrale